As part of a strategy to strengthen its immunology segment through acquisitions, Sanofi has agreed to purchase US-based Blueprint Medicines…
Read More
Winners Of Testsigma Customer Awards 2025 Announced: Sanofi, Nokia Among Honorees
San Francisco: On the occasion of World Tester’s Day, Testsigma announced the winners of the inaugural Testsigma Customer Awards 2025,…
Read More
Sanofi to acquire Blueprint Medicines
Blueprint’s most recently approved drug is Ayvakit, which the US Food and Drug Administration approved in 2020 to treat gastrointestinal…
Read More
